Enhancing CD19 chimeric antigen receptor T cells through memory-enriched T cells Editorial


Authors: El Marabti, E.; Abdel-Wahab, O.
Title: Enhancing CD19 chimeric antigen receptor T cells through memory-enriched T cells
Abstract: Chimeric antigen receptor T (CAR-T) cells directed against CD19 have transformed the therapy of relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL). A recent study reports promising activity and safety of CD19 CAR-T cells generated from naïve, stem, and central memory T cells in adults with R/R B-ALL. See related article by Aldoss et al., p. 742. ©2022 American Association for Cancer Research.
Keywords: adult; genetics; acute lymphoblastic leukemia; immunology; precursor cell lymphoblastic leukemia-lymphoma; biological therapy; adoptive immunotherapy; immunotherapy, adoptive; cd19 antigen; antigens, cd19; memory t lymphocyte; humans; human; cell- and tissue-based therapy; memory t cells; receptors, chimeric antigen
Journal Title: Clinical Cancer Research
Volume: 29
Issue: 4
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2023-02-15
Start Page: 694
End Page: 696
Language: English
DOI: 10.1158/1078-0432.Ccr-22-3232
PUBMED: 36507801
PROVIDER: scopus
PMCID: PMC9957814
DOI/URL:
Notes: Editorial -- Export Date: 1 March 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors